Detalles de la búsqueda
1.
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
Prostate
; 84(7): 636-643, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413843
2.
The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups.
Prostate
; 82(13): 1237-1247, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675470
3.
Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses.
J Urol
; 205(5): 1361-1371, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33356529
4.
Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone-sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study.
Int J Urol
; 28(7): 765-773, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33955599
5.
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study.
Int J Clin Oncol
; 25(3): 486-494, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31564004
6.
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study).
BMC Cancer
; 19(1): 339, 2019 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30971225
7.
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study.
Int J Clin Oncol
; 24(7): 848-856, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30741370
8.
Chronological changes in epidemiological characteristics of lower urinary tract urolithiasis in Japan.
Int J Urol
; 26(1): 96-101, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30308705
9.
Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma.
Int J Clin Oncol
; 23(5): 944-950, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29785621
10.
Near infrared fluorescence imaging system for laparoscopic partial nephrectomy.
Can J Urol
; 25(6): 9606-9613, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30553287
11.
Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction.
Int J Urol
; 25(3): 258-262, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29194771
12.
Chronological changes in the epidemiological characteristics of upper urinary tract urolithiasis in Japan.
Int J Urol
; 25(4): 373-378, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29648701
13.
14.
Prolonging survival in metastatic renal cell carcinoma patients treated with targeted anticancer agents: a single-center experience of treatment strategy modifications.
Can J Urol
; 22(3): 7798-804, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26068628
15.
[Bone and Calcium Research Update 2015. Clinical update of urolithiasis--ESWL (extracorporeal shock wave lithotripsy)].
Clin Calcium
; 25(1): 97-104, 2015 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-25530527
16.
Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.
BJU Int
; 113(2): 320-32, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24895689
17.
Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis.
Eur Urol Oncol
; 2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38072761
18.
The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES.
Eur Urol
; 84(2): 229-241, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37179240
19.
Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan.
Curr Med Res Opin
; 38(3): 417-426, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918590
20.
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
J Clin Oncol
; 40(15): 1616-1622, 2022 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35420921